top of page
Softly Lit Cortical Landscape_edited.jpg

Neuromodulatory Systems and Cognition Lab

By combining techniques ranging from computational modelling and neuroimaging to pharmacology and non-invasive brain stimulation, we aim to uncover the mechanisms through which neuromodulatory systems and their interactions drive learning, decision-making, and motivation in both humans and animal models.

1 / Computational Modelling of Behaviour

We develop computational models to understand how changes in behaviour are linked to activity within neuromodulatory systems. For example, we recently applied a general linear hidden Markov model (GLM-HMM) to identify transitions in motivational states in non-human primates.

Dorsal raphe nucleus controls motivation-state transitions in monkeys

2 / Neuroimaging

Using advanced neuroimaging in both humans and non-human primates, we relate activity in neuromodulatory nuclei to behaviour. Our work leverages 3T and ultra–high-field 7T fMRI, as well as magnetic resonance spectroscopy (MRS). For instance, we recently showed that activity in the human dorsal raphe nucleus — the brain’s main serotonergic centre — is associated with changes in behavioural policy.

Activity in human dorsal raphe nucleus signals changes in behavioural policy

Screenshot 2026-11-05 031042.png
3 / Psychopharmacology

Through systemic neuropharmacological interventions, we examine the causal relationships between major neuromodulatory systems and cognition. Our studies have shown, for example, that manipulating the brain’s cholinergic and serotonergic systems has opposite effects on decisions about when to initiate an action.

Complementary roles of serotonergic and cholinergic systems in decisions about when to act

4 / Neurostimulation with TUS

We employ non-invasive transcranial ultrasound stimulation (TUS) to causally manipulate activity in neuromodulatory nuclei. Recently, we demonstrated that disrupting activity in the dorsal raphe nucleus reduces sensitivity to reward contexts and perturbs transitions in motivational states.

A basal forebrain-cingulate circuit in macaques decides it is time to act

im4.png
5 / Targeted Drug Delivery with TUS

We also use TUS to transiently and non-invasively open the blood–brain barrier (BBB), enabling delivery of neuromodulatory agents such as serotonin and dopamine to specific brain regions. This approach allows us to investigate how precise modulation of these systems influences cognition and behaviour.

Ultrasound-mediated neuromodulator delivery reveals serotonergic control of context-dependent motivation in primates

NSCLab-MonkeyFriendlyFigure2.png

Our Team

Lab dinner, July 2025

Lab Alumni

Contact

GET IN TOUCH

Let’s collaborate

Drop us an email at nsclaboxford@gmail.com to explore potential collaborations, research partnerships, or to learn more about our ongoing projects.

  • LinkedIn
  • Facebook
  • Twitter

© 2035 by BizBud. Powered and secured by Wix

bottom of page